Feasibility study of combination therapy with S-1 plus irinotecan in patients with EGFR positive KRAS mutation type unresectable colorectal cancer, who had previously received on irinotecan, oxaliplat...

Update Il y a 4 ans
Reference: JPRN-UMIN000009734

Feasibility study of combination therapy with S-1 plus irinotecan in patients with EGFR positive KRAS mutation type unresectable colorectal cancer, who had previously received on irinotecan, oxaliplatin and fluoropyrimidine, bevacizumab

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract


Inclusion criteria

  • Colorectal Cancer

Links